×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
New Changes to the National Drug Code in the U.S.
Session Chair(s)
Leyla Rahjou-Esfandiary, PharmD
Lead CSO, Office of Compliance, CDER
FDA, United States
New Changes to the National Drug Code in the U.S.
Have an account?